` 2MT (Athenex Inc) vs DAX Index Comparison - Alpha Spread

A
2MT
vs
D
DAX Index

Over the past 12 months, 2MT has underperformed DAX Index, delivering a return of 0% compared to the DAX Index's +29% growth.

Stocks Performance
2MT vs DAX Index

Loading
2MT
DAX Index
Add Stock

Performance Gap
2MT vs DAX Index

Loading
2MT
DAX Index
Difference
www.alphaspread.com

Performance By Year
2MT vs DAX Index

Loading
2MT
DAX Index
Add Stock

Competitors Performance
Athenex Inc vs Peers

DAX Index
2MT
ABBV
AMGN
GILD
VRTX
Add Stock

Athenex Inc
Glance View

Market Cap
715.7m EUR
Industry
Biotechnology

Athenex, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of novel therapies for the treatment of cancer. The company is headquartered in Buffalo, New York and currently employs 652 full-time employees. The company went IPO on 2017-06-14. The Company’s platforms include Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. Oncology Innovation Platform is engaged in research and development of its drugs. Global Supply Chain Platform is engaged in supplying active pharmaceutical ingredient to clinical and commercial efforts. Commercial Platform includes specialty pharmaceuticals business, and manufacture and marketing of products. The Company’s product pipeline includes Orascovery, Src Kinase Inhibition, Cell Therapy and Arginine Deprivation Therapy. Its lead product candidate Orascovery platform technology is based on the oral P-gp pump inhibitor molecule, encequidar. The Src Kinase inhibition platform technology is based on small molecule compounds including the inhibition of the activity of Src Kinase and the inhibition of tubulin polymerization.

2MT Intrinsic Value
Not Available
A
Back to Top